Glucose B. Braun

Glucose B. Braun is an intravenous solution that contains glucose monohydrate as its active ingredient. It is supplied in a sterile liquid form for infusion into the bloodstream. The product is manufactured by B. Braun and is marketed in the European Union. It provides a source of carbohydrate energy that can be used in various clinical settings where rapid glucose delivery is required.

Glucose B. Braun is used in medical practice to supply carbohydrate calories and to maintain blood glucose levels during periods of fasting or increased metabolic demand. It may be administered in hospitals, surgical suites, and intensive care units as part of fluid therapy.

- Treatment of hypoglycemia when oral intake is not feasible - Provision of calories in parenteral nutrition regimens - Dilution and carrier for certain intravenous medications - Maintenance of fluid and electrolyte balance during surgery - Support for patients with limited oral intake or gastrointestinal dysfunction

Glucose B. Braun may cause a range of reactions, most of which are related to its carbohydrate content and the intravenous route of administration.

Common: - Mild hyperglycemia or elevated blood glucose levels - Local irritation at the infusion site - Nausea or mild gastrointestinal discomfort - Headache or dizziness - Transient changes in electrolyte balance - Mild allergic skin reactions such as rash

Serious: - Severe hyperglycemia leading to osmotic diuresis - Anaphylactic or severe allergic reaction - Fluid overload or pulmonary edema - Metabolic acidosis in susceptible patients - Hyperosmolar hyperglycemic state in diabetic individuals

When using Glucose B. Braun, clinicians should assess patient-specific factors and monitor for potential complications. Proper evaluation and monitoring help reduce risks associated with intravenous glucose administration.

- Verify blood glucose levels before and during infusion - Adjust infusion rate in patients with diabetes or impaired glucose tolerance - Monitor fluid balance to avoid overload, especially in cardiac or renal disease - Use caution in patients with electrolyte disturbances, particularly potassium and sodium - Assess for signs of allergic reaction during initial administration - Ensure compatibility with other IV solutions and medications before mixing - Follow aseptic technique to prevent catheter-related infections

Glucose B. Braun can interact with other medications or clinical conditions, influencing its safety and effectiveness. Awareness of these interactions helps guide appropriate use.

Avoid: - Co-administration with insulin or other hypoglycemic agents without dose adjustment - Use with hypertonic solutions that may exacerbate hyperosmolar states - Simultaneous infusion with drugs that require a specific pH or osmolarity incompatible with glucose solutions

Use with caution: - Concurrent administration of potassium-containing solutions (risk of hyperkalemia) - Patients receiving diuretics or corticosteroids (altered glucose metabolism) - Individuals on beta‑blockers (masked hypoglycemia symptoms) - Patients with renal impairment (fluid and electrolyte management) - Use with other carbohydrate-containing parenteral nutrition components (total caloric load)